Annual Total Long Term Liabilities
$50.45 M
+$22.71 M+81.85%
31 December 2023
Summary:
Voyager Therapeutics annual total long term liabilities is currently $50.45 million, with the most recent change of +$22.71 million (+81.85%) on 31 December 2023. During the last 3 years, it has risen by +$2.63 million (+5.51%). VYGR annual total long term liabilities is now -71.85% below its all-time high of $179.24 million, reached on 31 December 2019.VYGR Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$51.52 M
-$9.16 M-15.09%
30 September 2024
Summary:
Voyager Therapeutics quarterly total long term liabilities is currently $51.52 million, with the most recent change of -$9.16 million (-15.09%) on 30 September 2024. Over the past year, it has increased by +$1.07 million (+2.12%). VYGR quarterly long term liabilities is now -79.55% below its all-time high of $251.88 million, reached on 31 March 2019.VYGR Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VYGR Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +2.1% |
| 3 y3 years | +5.5% | +7.7% |
| 5 y5 years | -71.8% | -71.3% |
VYGR Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +81.8% | -48.2% | +85.7% |
| 5 y | 5 years | -71.8% | +81.8% | -71.3% | +85.7% |
| alltime | all time | -71.8% | -79.5% | +554.3% |
Voyager Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $51.52 M(-15.1%) |
| June 2024 | - | $60.68 M(+8.1%) |
| Mar 2024 | - | $56.15 M(+11.3%) |
| Dec 2023 | $50.45 M(+81.8%) | $50.45 M(-11.1%) |
| Sept 2023 | - | $56.74 M(-20.2%) |
| June 2023 | - | $71.11 M(-28.5%) |
| Mar 2023 | - | $99.39 M(+258.2%) |
| Dec 2022 | $27.75 M(-42.0%) | $27.75 M(-5.7%) |
| Sept 2022 | - | $29.41 M(-3.9%) |
| June 2022 | - | $30.62 M(-34.3%) |
| Mar 2022 | - | $46.57 M(-2.6%) |
| Dec 2021 | $47.82 M(-40.6%) | $47.82 M(-32.3%) |
| Sept 2021 | - | $70.65 M(-3.9%) |
| June 2021 | - | $73.50 M(-4.2%) |
| Mar 2021 | - | $76.76 M(-4.6%) |
| Dec 2020 | $80.50 M(-55.1%) | $80.50 M(+31.0%) |
| Sept 2020 | - | $61.47 M(-59.8%) |
| June 2020 | - | $153.04 M(-10.1%) |
| Mar 2020 | - | $170.32 M(-5.0%) |
| Dec 2019 | $179.24 M | $179.24 M(-4.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2019 | - | $187.89 M(-6.5%) |
| June 2019 | - | $201.04 M(-20.2%) |
| Mar 2019 | - | $251.88 M(+154.7%) |
| Dec 2018 | $98.91 M(+186.5%) | $98.91 M(-2.5%) |
| Sept 2018 | - | $101.45 M(-2.1%) |
| June 2018 | - | $103.60 M(-2.1%) |
| Mar 2018 | - | $105.79 M(+206.4%) |
| Dec 2017 | $34.53 M(-13.3%) | $34.53 M(-0.7%) |
| Sept 2017 | - | $34.77 M(-15.8%) |
| June 2017 | - | $41.29 M(-0.1%) |
| Mar 2017 | - | $41.33 M(+3.7%) |
| Dec 2016 | $39.84 M(+9.3%) | $39.84 M(+19.0%) |
| Sept 2016 | - | $33.47 M(-2.6%) |
| June 2016 | - | $34.35 M(+3.1%) |
| Mar 2016 | - | $33.31 M(-8.6%) |
| Dec 2015 | $36.45 M(+362.9%) | $36.45 M(-11.8%) |
| Sept 2015 | - | $41.35 M(-10.6%) |
| June 2015 | - | $46.26 M(+487.5%) |
| Dec 2014 | $7.87 M(>+9900.0%) | $7.87 M |
| Dec 2013 | $0.00 | - |
FAQ
- What is Voyager Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Voyager Therapeutics?
- What is Voyager Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Voyager Therapeutics?
- What is Voyager Therapeutics quarterly long term liabilities year-on-year change?
What is Voyager Therapeutics annual total long term liabilities?
The current annual total long term liabilities of VYGR is $50.45 M
What is the all time high annual total long term liabilities for Voyager Therapeutics?
Voyager Therapeutics all-time high annual total long term liabilities is $179.24 M
What is Voyager Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of VYGR is $51.52 M
What is the all time high quarterly long term liabilities for Voyager Therapeutics?
Voyager Therapeutics all-time high quarterly total long term liabilities is $251.88 M
What is Voyager Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, VYGR quarterly total long term liabilities has changed by +$1.07 M (+2.12%)